Real-World Characteristics and Outcomes Among Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) and HER2 Mutations

被引：0
|
作者：
Bath, Christina [1 ]
Le, Xiuning [2 ]
Lovly, Christine M. [3 ]
Patil, Tejas [4 ]
Maruti, Sonia S. [5 ]
Stanhope, Stephen A. [5 ]
Herbert, Stephan [6 ]
Nagasaka, Misako [7 ,8 ,9 ]
机构：
[1] Univ Washington, Seattle, WA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Univ Colorado, Sch Med, Aurora, CO USA
[5] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[6] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[7] Univ Calif Irvine, Sch Med, Orange, CA USA
[8] Chao Family Comprehens Canc Ctr, Orange, CA USA
[9] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.115
引用
收藏
页码：E49 / E50
页数：2
相关论文
共 50 条
  • [31] REAL-WORLD TREATMENT PATTERNS AMONG ADULT PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE US
    Chen, Y.
    Carlson, A.
    VALUE IN HEALTH, 2024, 27 (06) : S387 - S388
  • [32] Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer
    Divan, Hozefa A.
    Bittoni, Marisa A.
    Krishna, Ashok
    Carbone, David P.
    BMC CANCER, 2024, 24 (01)
  • [33] Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC)
    Pitiyarachchi, Omali
    Tan, Aaron C.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (02)
  • [34] HER2 copy number variation in non-small cell lung cancer (NSCLC)
    Tagliamento, M.
    Auclin, E.
    Valent, A.
    Ferrara, R.
    Cotteret, S.
    Rouleau, E.
    Caramella, C.
    Melia, M. Riudavets
    Gazzah, A.
    Adam, J.
    Jovelet, C.
    Bayle, A.
    Lacroix, L.
    Auger, N.
    Barlesi, F.
    Planchard, D.
    Besse, B.
    Mezquita, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1050 - S1050
  • [35] A real-world study on biomarker retesting among patients with non-small cell lung cancer and disparity in outcomes
    Crawford, Samuel
    Aggarwal, Charu
    Ng, Sophia
    Xu, Qingqing
    Simmons, Archana
    Gulati, Ashish
    Beasley, Mary Beth
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] Real-world characteristics and outcomes of patients with advanced non-small cell lung cancer (aNSCLC) receiving immune checkpoint inhibitor.
    Khozin, Sean
    Zhi, Jizu
    Jun, Monika
    Chen, Li
    Rubinstein, Wendy S.
    Walker, Mark S.
    Komatsoulis, George Anthony
    Roberts, Jeremy
    Fukushima, Ryan
    Lau, Denise
    Hyde, Brigham
    Stepanski, Edward
    Miller, Robert S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting
    Yang, Mo
    MacEwan, Joanna P.
    Boppudi, Sai Sriteja
    McClain, Monica
    O'Hara, Richard
    Liu, Frank
    Paik, Paul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] AUTOMATING THE IDENTIFICATION OF LINES OF THERAPY FROM REAL-WORLD DATA IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Li, X., I
    Hess, L.
    Goodloe, X.
    Wu, Y.
    Cui, Z.
    VALUE IN HEALTH, 2021, 24 : S57 - S57
  • [39] Nivolumab outcomes in interstitial lung disease patients with advanced non-small cell lung cancer in French real-world setting
    Assie, J-B.
    Chouaid, C.
    Nunes, H.
    Reynaud, D.
    Gaudin, A-F.
    Grumberg, V.
    Jolivel, R.
    Jouaneton, B.
    Cotte, F-E.
    Duchemann, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S1418 - S1418
  • [40] Real-World Characteristics and Outcomes of ERBB2-Mutant Non-small Cell Lung Cancer in Latin America Patients
    Saldanha, E.
    De Lima, V. C. C.
    Corassa, M.
    Arrieta, O.
    Fares, A.
    Santana, L. Gil
    Soler, J. A.
    Chamorro, D.
    Rodriguez, J.
    Freitas, H.
    Cardona, A. F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S661 - S661
12345